Cargando…
Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
BACKGROUND: Soluble amyloid-β (Aβ) oligomers are the major toxic substances associated with the pathology of Alzheimer’s disease (AD). The ability to measure Aβ oligomer levels in the blood would provide simple and minimally invasive tools for AD diagnostics. In the present study, the recently devel...
Autores principales: | Wang, Min Jeong, Yi, SangHak, Han, Jee-young, Park, So Young, Jang, Jae-Won, Chun, In Kook, Kim, Sang Eun, Lee, Byoung Sub, Kim, Gwang Je, Yu, Ji Sun, Lim, Kuntaek, Kang, Sung Min, Park, Young Ho, Youn, Young Chul, An, Seong Soo A., Kim, SangYun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732503/ https://www.ncbi.nlm.nih.gov/pubmed/29246249 http://dx.doi.org/10.1186/s13195-017-0324-0 |
Ejemplares similares
-
Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ(42)
por: An, Seong Soo A., et al.
Publicado: (2017) -
Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023) -
Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun, Jung-Min, et al.
Publicado: (2021) -
Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
por: Youn, Young Chul, et al.
Publicado: (2019) -
Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data
por: Youn, Young Chul, et al.
Publicado: (2022)